These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3881605)

  • 1. Leads from the MMWR. Adverse reactions to Fansidar and updated recommendations for its use in the prevention of malaria.
    JAMA; 1985 Jan; 253(4):483. PubMed ID: 3881605
    [No Abstract]   [Full Text] [Related]  

  • 2. Adverse reactions to Fansidar and updated recommendations for its use in the prevention of malaria.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Jan; 33(51-52):713-4. PubMed ID: 3917533
    [No Abstract]   [Full Text] [Related]  

  • 3. Fansidar for malaria prophylaxis.
    Kissane D
    Aust Fam Physician; 1985 Aug; 14(8):738. PubMed ID: 3901990
    [No Abstract]   [Full Text] [Related]  

  • 4. Leads from the MMWR. Revised recommendations for preventing malaria in travelers to areas with chloroquine-resistant Plasmodium falciparum.
    JAMA; 1985 May; 253(17):2483-6. PubMed ID: 3157011
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of pyrimethamine-sulfadoxine (Fansidar) in prophylaxis against chloroquine-resistant Plasmodium falciparum and Pneumocystis carinii.
    Pearson RD; Hewlett EL
    Ann Intern Med; 1987 May; 106(5):714-8. PubMed ID: 3551713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe cutaneous reactions among American travelers using pyrimethamine-sulfadoxine (Fansidar) for malaria prophylaxis.
    Miller KD; Lobel HO; Satriale RF; Kuritsky JN; Stern R; Campbell CC
    Am J Trop Med Hyg; 1986 May; 35(3):451-8. PubMed ID: 2939735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatal Stevens-Johnson syndrome associated with Fansidar and chloroquine.
    Bamber MG; Elder AT; Gray JA; Minns RA
    J Infect; 1986 Jul; 13(1):31-3. PubMed ID: 3734464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revised recommendations for preventing malaria in travelers to areas with chloroquine-resistant Plasmodium falciparum.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Apr; 34(14):185-90, 195. PubMed ID: 3156271
    [No Abstract]   [Full Text] [Related]  

  • 9. Boxed warning added to Fansidar labeling.
    FDA Drug Bull; 1985 Aug; 15(2):21. PubMed ID: 4054454
    [No Abstract]   [Full Text] [Related]  

  • 10. Leads from the MMWR. Need for malaria prophylaxis by travelers to areas with chloroquine-resistant Plasmodium falciparum.
    JAMA; 1986 Feb; 255(5):597. PubMed ID: 3003409
    [No Abstract]   [Full Text] [Related]  

  • 11. Unusual pulmonary reaction during short term prophylaxis with pyrimethamine-sulfadoxine (Fansidar).
    Svanbom M; Rombo L; Gustafsson L
    Br Med J (Clin Res Ed); 1984 Jun; 288(6434):1876. PubMed ID: 6428585
    [No Abstract]   [Full Text] [Related]  

  • 12. Does chloroquine contribute to the risk of serious adverse reactions to fansidar?
    Rombo L; Stenbeck J; Lobel HO; Campbell CC; Papaioanou M; Miller KD
    Lancet; 1985 Dec; 2(8467):1298-9. PubMed ID: 2866354
    [No Abstract]   [Full Text] [Related]  

  • 13. Adverse reactions to sulphadoxine-pyrimethamine in Swedish travellers: implications for prophylaxis.
    Hellgren U; Rombo L; Berg B; Carlson J; Wiholm BE
    Br Med J (Clin Res Ed); 1987 Aug; 295(6594):365-6. PubMed ID: 2958104
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment failure of falciparum malaria with Fansidar in Tawau Sabah. January-June, 1982.
    Tan Heng Soon ; Tan Puay Eng
    Med J Malaysia; 1983 Sep; 38(3):217-23. PubMed ID: 6369092
    [No Abstract]   [Full Text] [Related]  

  • 15. Leads from the MMWR. Fansidar-associated fatal reaction in an HIV-infected man.
    JAMA; 1988 Oct; 260(15):2193. PubMed ID: 3262778
    [No Abstract]   [Full Text] [Related]  

  • 16. Need for malaria prophylaxis by travelers to areas with chloroquine-resistant Plasmodium falciparum.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Jan; 35(2):21-22, 27. PubMed ID: 3001495
    [No Abstract]   [Full Text] [Related]  

  • 17. [The reliability and side effects of malaria chemoprophylaxis].
    Steffen R; Heusser R
    Schweiz Rundsch Med Prax; 1986 Apr; 75(16):446-8. PubMed ID: 2939527
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chloroquine and fansidar resistance of Plasmodium falciparum now also in Ghana].
    Kupferschmidt HG; Schröder K; Beltzner B
    Angew Parasitol; 1988 Nov; 29(4):211-3. PubMed ID: 3072886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chemoprophylaxis of malaria.
    Chiodini PL
    J Antimicrob Chemother; 1987 Sep; 20(3):297-302. PubMed ID: 3316145
    [No Abstract]   [Full Text] [Related]  

  • 20. Chloroquine resistance in Plasmodium falciparum in KwaZulu, 1983-1988.
    Hansford CF
    S Afr Med J; 1989 Nov; 76(10):546-7. PubMed ID: 2686047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.